Nasdaq:US$13.81 (+0.07) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
Shareholder Information

EVENTS, PRESENTATIONS & CIRCULARS


2022 Full Year Financial Results 2023-02-28
Corporate Presentation for Investors 2023-02-01
Company Update: Fruquintinib Development and Commercialization Outside China 2023-01-23
Deutsche Bank ADR Virtual Investor Conference (dbVIC) 2022-11-17